UPDATE : Saturday, February 22, 2020
상단여백
'Insulin is safe, natural replacement therapy for diabetic patients' by Lee Han-soo 2019-12-04 17:07
SK Biopharm set to ensure superiority in antiepileptic drug by Jeong Sae-im 2019-12-04 16:18
Hanmi licenses in US firm’s oral immunotherapy candidate by Lee Han-soo 2019-12-04 16:16
ISU Abxis starts trial of Gaucher disease treatment in Australia by Lee Han-soo 2019-12-04 16:16
Samyang Biopharm’s US subsidiary to work on new immunotherapy by Jeong Sae-im 2019-12-03 15:37
라인
Ildong signs co-promotion contract with GSK Consumer Healthcare by Lee Han-soo 2019-12-03 15:18
Global diabetes group opens 5-day show in Busan by Lee Han-soo 2019-12-03 11:04
LG Chem licenses in US firm’s diagnostic platform tech by Lee Han-soo 2019-12-02 13:42
Syntekabio views industry’s crisis as opportunity by Jeong Sae-im 2019-11-29 17:54
S. Biomedics to test embryonic stem cell-derived spinal cord injury treatment by Lee Han-soo 2019-11-29 15:42
라인
Daewoong challenges gastric acid blocker K-Cab with Fexuprazan by Jeong Sae-im 2019-11-29 15:23
Hanmi's Chinese partner to start trials for anticancer treatment by Lee Han-soo 2019-11-28 17:38
GI Innovation licenses out immunotherapy drug candidate to Chinese firm by Lee Han-soo 2019-11-28 16:26
Takeda's ovarian cancer drug Zejula to get insurance benefit by Lee Han-soo 2019-11-28 15:36
ST Pharm submits IND application for colorectal cancer treatment in US by Lee Han-soo 2019-11-28 14:52
라인
New Parkinson’s drug Ongentys lands on Korea by Jeong Sae-im 2019-11-28 14:52
Experts ascribe excessive diabetes hospitalization to lack of early treatment by Lee Han-soo 2019-11-28 11:26
Bristol-Myers Squibb Korea names new CEO by Lee Han-soo 2019-11-28 11:26
SK Chemicals wins FDA nod for patch-type Alzheimer’s drug by Jeong Sae-im 2019-11-27 18:24
Daewoong ends P3 trial for drug treating gastroesophageal reflux disease by Lee Han-soo 2019-11-27 18:21
여백
여백
여백
Back to Top